In recent years, generative artificial intelligence and large-scale pre-trained language models have shown a rapid development trend, which has triggered far-reaching technological changes and extensive application integration in the field of medical service. Many aspects, from intelligent diagnosis and treatment to precision medicine, to data-driven decision support systems, have been significantly and profoundly affected by it.

"2024 China AI Medical Industry Research Report" pointed out that in the medical field, AI application is increasingly widespread, through the integration of information technology, to achieve intelligent, efficient and convenient medical services, covering intelligent diagnosis, treatment, management and other links, enabling the whole process of medical services, improve efficiency and quality.

At present, the Internet medical industry is enhancing the ability of medical services through the innovative application of AI, providing a new solution path for key issues such as chronic disease intervention and management and healthy aging.

As a leading Internet medical enterprise, FangzhouYunkang Holdings Co., LTD. (hereinafter referred to as "FangzhouYunkang") makes full use of emerging technologies such as artificial intelligence, cloud computing and big data to promote the continuous breakthrough and application of medical technology. Its well-known brand FangzhouJianke has successfully developed into the largest online chronic disease management service platform in China.

Through technological innovation, Fangzhou Yunkang continuously optimizes platform services, innovates and builds an H2H (Hospital to Home, from hospital to home) smart medical business ecosystem, uses AI technology to provide users with personalized health management solutions, and provides more accurate and professional chronic disease services around real medical needs.

At present, Fang ZhouYunkang's chronic disease management service has covered tens of millions of users, helping patients manage their health more effectively through artificial intelligence technology. Through the H2H service platform (Hospital to Home from hospital to home) smart medical business ecosystem, the links of medical service, chronic disease management, doctor-patient education and drug supply extend from the hospital to the patient's home, significantly improving the patient's medical experience and the timeliness of medical services. At the same time, relying on a strong drug supply chain, Fangzhou Yunkang provides more health protection for patients with chronic diseases.

It is reported that in November 2024, Fangzhou Yunkang took the lead in the industry to release the "AI agent solution", and its innovative research and development of three intelligent application scenarios - "AI personal health assistant", "AI academic interactive assistant" and "intelligent medical record collection system", both ordinary users and medical professionals can quickly obtain the required information and data analysis results. This innovation not only provides users with a new way of health management, but also further enhances Fangzhou Yunkang's core competitiveness and brand influence in the field of Internet medical care.

Driven by the wave of digitalization, Fangzhou Yunkang, with its deep application of cutting-edge technologies such as artificial intelligence and big data, is helping to improve the high-quality development of chronic disease management services and promote innovation and change in the field of Internet medical services. Looking to the future, Fangzhou Yunkang will continue to deepen technology empowerment, promote the development of Internet medical to a more efficient, intelligent and personalized direction, and is committed to bringing a healthier life to more people.